The AUC of
tolterodine is raised by more than 2-fold by
ketoconazole. Itraconazole is predicted to interact similarly.
The UK manufacturers advise avoiding concurrent use. The US manufacturers suggest reducing the
tolterodine dose to 1 mg twice daily, which seems practical. If both drugs are given monitor carefully for
tolterodine adverse effects, and further reduce the dose if necessary.